Loading...

China Oncology

28 February 2025, Volume 35 Issue 2
Cover and contents

2025 Issue 2 Cover

Abstract ( 48) PDF (4344KB) ( 49 )

Contents of Issue 2, 2025

2025, 35 (2): 2-2.

Abstract ( 25) PDF (10551KB) ( 28 )

Specialist's Commentary

Significant fundamental translational research on breast cancer in China: progress and prospects

LU Yufeng, WANG Han, XIE Yifan, JIANG Yizhou, SHAO Zhimin

2025, 35 (2): 143-153. doi: 10.19401/j.cnki.1007-3639.2025.02.001

Abstract ( 127) PDF (1502KB) ( 228 ) HTML ( 13 )

Current status and future perspectives of antibody-drug conjugates in breast cancer therapy

LIN Jialin, WANG Wenna, XU Binghe

2025, 35 (2): 154-166. doi: 10.19401/j.cnki.1007-3639.2025.02.002

Abstract ( 94) PDF (1258KB) ( 231 ) HTML ( 9 )

Progress of important clinical research on breast cancer in China in 2024

YANG Xin, SHI Qianfeng, LIU Qiang

2025, 35 (2): 167-175. doi: 10.19401/j.cnki.1007-3639.2025.02.003

Abstract ( 135) PDF (1132KB) ( 290 ) HTML ( 14 )

Important research progress in clinical practice for early breast cancer in 2024

LI Xing, PENG Ziqi, YU Xinmiao, JIN Feng

2025, 35 (2): 176-185. doi: 10.19401/j.cnki.1007-3639.2025.02.004

Abstract ( 108) PDF (1161KB) ( 300 ) HTML ( 8 )

Important clinical studies that changed the clinical practice of advanced breast cancer in 2024

WU Song, YUAN Yang, JIANG Zefei

2025, 35 (2): 186-194. doi: 10.19401/j.cnki.1007-3639.2025.02.005

Abstract ( 87) PDF (1140KB) ( 182 ) HTML ( 4 )

Advances in immune checkpoint inhibitor therapy for breast cancer: research progress and future directions

ZENG Cheng, WANG Yuanyi, WANG Jiani, MA Fei

2025, 35 (2): 195-204. doi: 10.19401/j.cnki.1007-3639.2025.02.006

Abstract ( 120) PDF (1182KB) ( 208 ) HTML ( 5 )

Progress and future prospects in local and systemic treatment of early breast cancer

LI Junjie

2025, 35 (2): 205-212. doi: 10.19401/j.cnki.1007-3639.2025.02.007

Abstract ( 76) PDF (1127KB) ( 184 ) HTML ( 1 )

Current status and prospects of tertiary lymphoid structure heterogeneity in predicting response to neoadjuvant therapy and characterizing immune microenvironment in triple-negative breast cancer

WANG Qing, YU Yushuai, WANG Chenxi, JIANG Zirong, LI Jialu, TANG Shicong, SONG Chuangui

2025, 35 (2): 213-218. doi: 10.19401/j.cnki.1007-3639.2025.02.008

Abstract ( 67) PDF (1070KB) ( 157 ) HTML ( 4 )

Comparison and review of updated guidelines for advanced gastric cancer diagnosis and treatment in 2024: CSCO, NCCN and ESMO

LAN Yu, WANG Fenghua

2025, 35 (2): 219-227. doi: 10.19401/j.cnki.1007-3639.2025.02.009

Abstract ( 182) PDF (1090KB) ( 227 ) HTML ( 10 )

Specialist's Article

Retrospective study on regional lymph node radiotherapy after axillary dissection exemption in breast cancer patients with sentinel lymph node positive status

LU Yongjin, SHI Zhiqiang, LI Tong, WANG Yongsheng, QIU Pengfei

2025, 35 (2): 228-236. doi: 10.19401/j.cnki.1007-3639.2025.02.010

Abstract ( 83) PDF (1202KB) ( 163 ) HTML ( 8 )

Article

Cost-effectiveness of PD-L1 testing to guide immunotherapy for patients with non-small cell lung cancer in China

LI Yuan, GUO Lingchuan, YUAN Yong, ZHENG Qiang, JIN Yan, MING Jian

2025, 35 (2): 237-248. doi: 10.19401/j.cnki.1007-3639.2025.02.011

Abstract ( 90) PDF (1272KB) ( 159 ) HTML ( 4 )

Review

Latest progress and prospect of NRP-1 targeted molecular probes for breast cancer diagnosis

CAI Shuyue, XIE Quan, ZHOU Yuxuan, LIU Qingzhu, QIU Ling, LIN Jianguo

2025, 35 (2): 249-254. doi: 10.19401/j.cnki.1007-3639.2025.02.012

Abstract ( 79) PDF (953KB) ( 141 ) HTML ( 6 )

中国癌症杂志
    Database Indexing
  • A Guide to the Core Journals of China
  • Chinese Science Citation Database (CSCD)
  • China National Knowledge Infrastructure (CNKI)
  • Chinese Sci-tech Paper and Citation Database (CSTPCD)
  • Outsanding S&T Journals of China (2020) (F5000)
  • World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
  • SCOPUS
  • EMBASE
  • DOAJ
  • Chemical Abstracts (CA)
  • Japan Science and Technology Database (JST)
  • The Western Pacific Region Index Medicus (WPRIM)
  • EBSCO
  • Index of Copernicus International (ICI)

Competent Authorities

 The Ministry of Education of the People’s Republic of China

Sponsored by

 Fudan University Shanghai Cancer Center

Edited by

 Editorial Board of China Oncology

Editor-in-Chief

 SHAO Zhimin

Honorary Editor-in-Chief

 TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

 Shanghai Ouyang Printing Co., Ltd.

WeChat